Literature DB >> 4012536

Management of burns in pregnant women.

E A Deitch, D A Rightmire, J Clothier, N Blass.   

Abstract

Although few women sustain thermal injuries during pregnancy, when pregnancy is complicated by thermal injury a clear management scheme plus a team approach is needed to provide optimal care to both the fetus and mother. The clinical courses of 11 pregnant women treated at the Louisiana State University Medical Center after sustaining thermal injuries were reviewed and combined with 29 other instances from the literature. Fetal survival before 28 weeks of gestation appears to be dependent upon maternal survival. After 32 weeks of gestational age, fetal survival becomes increasingly independent of maternal survival if fetal distress can be minimized. Although in general, optimal care of the fetus coincides with the care of the mother, occasionally the medical needs of the mother and fetus are different. Therefore, we have developed maternal and fetal medical care schemes to serve as general guidelines for the care of the pregnant patients with burns.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4012536

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  4 in total

1.  [Burns and pregnancy: report on two cases and review of the literature].

Authors:  A Khales; A Achbouk; S Siah; H Ihrai
Journal:  Ann Burns Fire Disasters       Date:  2010-06-30

2.  Maternal and foetal outcome of burns during pregnancy in kermanshah, iran.

Authors:  N Rezavand; A Seyedzadeh
Journal:  Ann Burns Fire Disasters       Date:  2006-12-31

3.  Burn injuries during pregnancy: an African series.

Authors:  O A Mabogunje
Journal:  J Natl Med Assoc       Date:  1990-09       Impact factor: 1.798

4.  Burns in pregnancy: Five-year experience in a tertiary hospital in southeastern Nigeria.

Authors:  Ugochukwu U Nnadozie; Charles C Maduba; Gabriel M Okorie; Lucky O Lawani; Anikwe C Chidebe; Obiora G K Asiegbu; Amaechi Ugbala
Journal:  Malawi Med J       Date:  2021-09       Impact factor: 0.875

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.